Q4 2023 Holdings
Filed 2024-02-14 | 23 holdings | $4.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kenvue Inc.(KVUE) | COM | 49177J102 | $3.9B | 182,329,550 | 89.5% |
| CVRx, Inc.(CVRX) | COM | 126638105 | $109.9M | 3,495,575 | 2.5% |
| Protagonist Therapeutics Inc.(PTGX) | COM | 74366E102 | $56.2M | 2,449,183 | 1.3% |
| Legend Biotech Corporation(LEGN) | ADS | 52490G102 | $49.0M | 814,586 | 1.1% |
| MeiraGTx Holdings plc(MGTX) | COM | G59665102 | $46.6M | 6,641,064 | 1.1% |
| Nanobiotix S.A.(NBTX) | SPONSORED ADS | 63009J107 | $40.9M | 5,623,816 | 0.9% |
| Fusion Pharmaceuticals Inc. | COM | 36118A100 | $35.3M | 3,670,516 | 0.8% |
| Shockwave Medical, Inc.(SWAVUSD) | COM | 82489T104 | $31.8M | 166,812 | 0.7% |
| Neumora Therapeutics, Inc.(NMRA) | COM | 640979100 | $31.5M | 1,849,445 | 0.7% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $15.9M | 748,062 | 0.4% |
| Procept BioRobotics Corporation(PRCT) | COM | 74276L105 | $15.0M | 357,939 | 0.3% |
| Fate Therapeutics, Inc.(FATE) | COM | 31189P102 | $12.6M | 3,379,064 | 0.3% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | COM | 04280A100 | $7.6M | 247,598 | 0.2% |
| Vor Biopharma, Inc. | COM | 929033108 | $2.4M | 1,074,658 | 0.1% |
| Nano-X Imaging Ltd.(NNOX) | ORD SHS | M70700105 | $2.0M | 317,704 | 0.0% |
| Adicet Bio, Inc.(TORCEUR) | COM | 007002108 | $1.3M | 688,595 | 0.0% |
| Aldeyra Therapeutics, Inc.(ALDX) | COM | 01438T106 | $1.1M | 299,669 | 0.0% |
| SomaLogic, Inc.(SLGCUSD) | COM | 83444K105 | $711.1K | 281,052 | 0.0% |
| BiomX Inc. | COM | 09090D103 | $597.4K | 2,133,402 | 0.0% |
| Clearside Biomedical, Inc.(CLSDUSD) | COM | 185063104 | $198.5K | 169,629 | 0.0% |
| Senseonics Holdings, Inc.(SENS1GBP) | COM | 81727U105 | $31.1K | 54,621 | 0.0% |
| Tracon Pharmaceuticals, Inc. | COM | 89237H209 | $14.7K | 84,003 | 0.0% |
| Apollomics, Inc. | CL A SHS | G0411D107 | $12.8K | 13,252 | 0.0% |